Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Classement en actions #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Prix de l'action
$0.0003
Dernière synchronisation: 2023-06-13
Capitalisation boursière
$28.14K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Neuropathix, Inc. (NPTX)

Catégorie

Ratio P/B pour Neuropathix, Inc. (NPTX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Neuropathix, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Neuropathix, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE